Monebo Technologies and Innolitics announced on 27 October 2026 that FDA has granted 510(k) clearance to the Kinetic Software Library, a cross-platform ECG arrhythmia analysis API the Austin, Texas company licenses to device manufacturers. The FDA's own database lists the clearance decision, K260640, as dated 23 October 2026. It is the newest entry in a predicate lineage Monebo traces back more than twenty years, to an arrhythmia-detection library it first cleared in 2005.
Monebo's clearance, in four figures
Figures from the FDA 510(k) database and Monebo and Innolitics' 27 October 2026 announcement.
What K260640 actually covers
The Kinetic Software Library is not a finished ECG monitor; it is the analysis layer inside one. A device manufacturer licenses the library and calls it through a cross-platform API, and Monebo's algorithms handle beat detection, heart-rate calculation and rhythm analysis on whatever ECG signal the manufacturer's own hardware captures. That business model — licensing the interpretation software rather than selling a labeled device — is why Monebo's own announcement credits the clearance to two companies: Monebo built and tested the library, and Innolitics led the FDA regulatory strategy, guided the required software and cybersecurity documentation, and managed the agency submission and interactions.
“Monebo's arrhythmia analysis has been inside ECG products for more than twenty years,” Dale Misczynski, President and Chief Executive Officer, Monebo Technologies — in the company's 27 October 2026 announcement
Twenty years of beats, re-packaged as an API
Monebo's clearance history runs back further than most software vendors still operating in the category: FDA cleared the Monebo Automatic Arrhythmia Detection Software Library, Version 1 (K043380) in 2005, and a successor, the Monebo Automated ECG Analysis and Interpretation Software Library, Version 3.0 (K062282), in 2007 — the same year Monebo partnered with chipmaker Freescale Semiconductor on an early ECG-on-a-chip platform. George Hattub, a senior Innolitics regulatory affairs project manager, led the Kinetic Software Library submission; Innolitics' own public count puts it as his 72nd FDA 510(k) clearance. Monebo says more than fifty later industry clearances trace their predicate lineage back to its original library, a claim this report attributes to the company rather than to an independent audit of FDA's predicate database.
Three reasons device makers license rather than build
A two-decade predicate trail
Building a new arrhythmia-detection algorithm from scratch means establishing substantial equivalence with no prior art; licensing Kinetic inherits Monebo's predicate lineage back to 2005, a shorter path through FDA review for the manufacturer that embeds it.
A regulatory partner, not just a library
Innolitics' role covered the software and cybersecurity documentation FDA now expects for any embedded algorithm, work a device manufacturer would otherwise have to staff or contract separately before it could even file.
Cross-platform by design
A single API that works across a manufacturer's own hardware lets a device company add arrhythmia analysis without redesigning its signal-acquisition path around a particular vendor's chipset or sensor.
A software category five times apart, by whose count
How big is the market Kinetic just cleared into? It depends entirely on which research firm is counting. Data Horizzon Research sizes the global ECG analysis software market at roughly $4.8 billion in 2024, growing to about $8.1 billion by 2033. Future Market Report, covering what it calls the same electrocardiograph analysis software category, puts 2026 at just $780.5 million and 2033 at $1.4 billion — a figure roughly five to six times smaller at every point of overlap. Neither publisher discloses enough methodology in its public summary to explain the gap, which likely comes down to whether hardware-bundled analysis features are counted as part of the device or as separate software revenue.
Two very different prices on the same category
$4.8B → $8.1B
Global ECG analysis software market, 2024 actual to 2033 forecast, per Data Horizzon Research; Future Market Report's much smaller forecast for the same named category is shown for comparison.
Sources: Data Horizzon Research, Electrocardiograph (ECG) Analysis Software Market · Future Market Report, Electrocardiograph (ECG) Analysis Software Market
Regulatory News outlook
Kinetic's revenue comes from per-device or per-license fees paid by device manufacturers, not from a hospital or consumer purchase, so it sits closer to Future Market Report's narrower, software-licensing-only framing than to Data Horizzon's larger figure, which may fold in hardware-bundled analysis features Monebo does not sell directly.
How we got here: We have not picked a single dollar estimate for Kinetic specifically, because the two publishers' figures differ by roughly 5 to 6 times at every comparable year and neither discloses the scope definition needed to reconcile them; stating a false middle number would manufacture precision neither report supports.
Kinetic against the algorithms already inside devices
| Product | Model | FDA status |
|---|---|---|
| Kinetic Software Library (Monebo / Innolitics) | Licensed cross-platform API | 510(k) cleared, Oct 2026 (K260640) |
| Marquette 12SL (GE HealthCare) | Licensed interpretation algorithm, bundled into GE and third-party ECG hardware | 510(k) cleared (established device) |
| DXL ECG Algorithm (Philips) | Licensed interpretation algorithm, bundled into Philips ECG hardware | 510(k) cleared (established device) |
| Kardia algorithm (AliveCor) | Direct-to-consumer app paired with AliveCor's own hardware | FDA cleared (established device) |
From each company’s own labelling and FDA clearance records; not a clinical comparison. GE's Marquette 12SL and Philips' DXL are long-established licensed algorithms, not newly cleared products.
From a 2005 library to a 2026 cross-platform API
Monebo's two decades of predicate lineage
- 2002
Monebo Technologies founded
Founded in Austin, Texas, to build ECG arrhythmia-analysis software for device manufacturers.
- 2005
First FDA clearance
The Monebo Automatic Arrhythmia Detection Software Library, Version 1 (K043380), clears FDA — the predicate Monebo traces its later clearances back to.
- 2007
Version 3.0 cleared; Freescale partnership
A successor library (K062282) clears FDA the same year Monebo and Freescale Semiconductor announce an ECG-on-a-chip platform, and Monebo's CardioBelt electrode system reaches market.
- 23 October 2026
Kinetic Software Library cleared
FDA grants 510(k) clearance (K260640) to the Kinetic Software Library, per the agency's own database.
- 27 October 2026
Clearance announced
Monebo and Innolitics publicly announce the clearance, crediting Innolitics with leading the FDA regulatory strategy and submission.
- Ahead
Available to device manufacturers
Monebo says it is now making the Kinetic Software Library available to ECG device manufacturers and will keep partnering with Innolitics as the library grows.
What this clearance does not resolve: Monebo's own figure of more than fifty later clearances tracing predicate lineage to its library is a company claim this report has not independently verified against FDA's predicate database, and neither Monebo nor Innolitics named a launch customer or disclosed Kinetic's licensing terms. Current leadership at Monebo beyond CEO Dale Misczynski, and the company's relationship, if any, to its 2021-reported acquisition by a holding group, were not confirmed well enough to state here.
- Clearance: FDA 510(k) K260640 for the Kinetic Software Library, decision dated 23 October 2026, announced 27 October 2026.
- Division of labor: Monebo built and tested the library; Innolitics led the FDA regulatory strategy, documentation and submission.
- Lineage: traces back to Monebo's first cleared library in 2005 (K043380) and a 2007 successor (K062282).
- Not yet public: licensing terms, a named launch customer, and an independently verified count of downstream clearances built on Monebo's predicate.
Sources & further reading
- Monebo Technologies and Innolitics, “Monebo and Innolitics Secure FDA 510(k) Clearance for a Cross-Platform ECG Arrhythmia Analysis Library,” 27 October 2026. 01net.it
- FDA 510(k) Premarket Notification database, Kinetic Software Library, K260640. accessdata.fda.gov
- Innolitics FDA 510(k) Search, Monebo Automatic Arrhythmia Detection Software Library, Version 1 (K043380). fda.innolitics.com
- Monebo Technologies, ECG Analysis Software product page. monebo.com
- BioSpace (press-release wire), “Freescale and Monebo Partner to Deliver Innovative Heart Monitoring Platform,” 2007. biospace.com
- Data Horizzon Research, Electrocardiograph (ECG) Analysis Software Market. datahorizzonresearch.com
- Future Market Report, Electrocardiograph (ECG) Analysis Software Market. futuremarketreport.com
Regulatory News reports on public regulatory documents. It is not legal advice, and the primary sources above govern. If we have made an error, we will say so in public: see corrections.
Frequently asked questions
What did FDA clear, and when?
FDA granted 510(k) clearance (K260640) to the Kinetic Software Library on 23 October 2026, per the FDA's own device database; Monebo Technologies and Innolitics announced the clearance publicly on 27 October 2026. The library is a cross-platform ECG arrhythmia analysis API that device manufacturers embed into their own hardware rather than a finished product a patient or clinician buys directly.
What does the Kinetic Software Library actually do?
It is an ECG analysis library covering beat detection, heart-rate calculation and rhythm analysis, which a device manufacturer integrates into its own ECG hardware through a cross-platform API, according to Monebo's product page. Monebo built and tested the library; Innolitics led the FDA regulatory strategy, guided the required software and cybersecurity documentation, and managed the FDA submission.
Is this Monebo's first FDA clearance?
No. Monebo's predecessor libraries were cleared in 2005 (K043380) and 2007 (K062282), and the company says its arrhythmia-analysis technology has been embedded in ECG products for more than twenty years. The Kinetic Software Library clearance is the newest entry in that lineage, not a first-time filing.
Who is Innolitics, and what was its role?
Innolitics is a medical-device software and regulatory consultancy that led the FDA regulatory strategy for the Kinetic Software Library submission, guided Monebo's engineers through the required software and cybersecurity documentation, and managed all FDA interactions. Innolitics also hosts a public FDA 510(k) search tool that mirrors agency clearance records, including Monebo's own 2005 and 2007 filings.
